Clinical trials will test a candidate vaccine for H7N9 flu in varying doses, some with immune boosters.
Resources & Literature
Recent Literature
Adedinsewo DA, Noory L, Badnarczyk RA, et al. Impact of maternal characteristics on the effect of maternal influenza vaccination on fetal outcomes. Vaccine 2013 (published online Oct 10)
Ahmed F, Lindley MC, Allred Norma, et al. Effect of influenza vaccination of health care personnel on morbidity and mortality among patients: systematic review and grading of evidence. Clin Infect Dis 2013 (published online Sep 17)
Baguelin M, Flasche S, Camacho A, et al. Assessing optimal target populations for influenza vaccination programs: an evidence synthesis and modeling study. PLoS Med 2013 Oct 8;10(10):e1001527
Bateman AX, Kieke BA, Irving SA, et al. Effectiveness of monovalent A(H1N1)pdm09 and 2010-11 trivalent inactivated influenza vaccines in Wisconsin during the 2010-11 season. J Infect Dis 2013 Apr 15;207(8):1262-9
Benchimol EI, Hawken S, Kwong JC, et al. Safety and utilization of influenza immunization in children with inflammatory bowel disease. Pediatrics 2013 (published online May 6)
Bodewes R, Fraaij PLA, Kreijtz JHCM, et al. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 2012 Dec 7;30(51):7407-10
Bragstad K, Emborg HD, Fischer TK, et al. Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 -- a rapid epidemiological and virological assessment. Euro Surveill 2013 Feb 7;18(6):pii=20397
Castilla J, Godoy P, Dominguez A, et al. Influenza vaccine effectiveness in preventing out-patient, in-patient and severe cases of laboratory-confirmed influenza. Clin Infect Dis 2013 Jul 15;57(2):167-75
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12. Euro Surveill 2013 Jan 31;18(5):pii=20388
Castilla J, Martinez-Baz I, Martinez-Artola V, et al. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis. Euro Surveill 2013 Feb 14;18(7):pii=20404
CDC. Influenza vaccination practices of physicians and caregivers of children with neurologic and neurodevelopmental conditions — United States, 2011-12 influenza season. MMWR 2013 Sep 13;62(36):744-6
CDC. Prevention and control of influenza with vaccines: interim recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013. MMWR 2013 May 10;62(18):356
CDC. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices—United States, 2013-2014. MMWR 2013 (published online Sep 20)
Cheng AC, Holmes M, Irving LB, et al. Influenza vaccine effectiveness against hospitalisation with confirmed influenza in the 2010-11 seasons: a test-negative observational study. PLoS One 2013 Jul 16;8(7):e68760
De Serres G, Skowronski DM, Wu XW, et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 2013;18(37):pii=20585
DiazGranados CA, Denis M, Plotkin S. Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine 2012 Dec 17;31(1):49-57
Domachowske JB, Pankow-Culot H, Bautista M, et al. A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years. J Infect Dis 2013 207(12):1878-87
Foppa IM, Haber M, Ferdinands JM, et al. The case test-negative design for studies of the effectiveness of seasonal influenza vaccine. Vaccine 2013 Jun 26;31(20):3104-9
Gorse GJ, Falsey AR, Fling JA, et al. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age. Vaccine 2013 May 1;31(19):2358-65
